Related Experiment Video
Updated: May 25, 2026
03:25
Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Antibiotics as immunomodulant agents in COPD.
Francesco Blasi1, Marco Mantero, Stefano Aliberti
1Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, University of Milan, IRCCS Fondazione Cà Granda Ospedale Maggiore, Milan, Italy. francesco.blasi@unimi.it
Current Opinion in Pharmacology
|February 11, 2012
Summary
Macrolide antibiotics, known for anti-inflammatory effects, can reduce exacerbations in chronic obstructive pulmonary disease (COPD). Research explores these benefits beyond antibacterial action for COPD management.
Area of Science:
- Pharmacology
- Immunology
- Respiratory Medicine
Background:
- Antibiotics possess non-antibacterial properties, including immunomodulatory and anti-inflammatory effects.
- Macrolides exhibit well-documented immunomodulatory activities, with growing evidence in chronic obstructive pulmonary disease (COPD) management.
- Fluoroquinolones also show immunomodulatory potential, though clinical data in COPD is limited.
Purpose of the Study:
- To review the significance of antibiotic immunomodulatory and anti-inflammatory effects in managing COPD.
- To highlight the role of macrolides in reducing COPD exacerbations and improving patient outcomes.
- To discuss novel macrolide derivatives lacking antibacterial activity.
Main Methods:
- Literature review of clinical studies and scientific evidence.
- Analysis of macrolide and fluoroquinolone immunomodulatory effects.
- Evaluation of antibiotic impact on COPD exacerbation rates, morbidity, and mortality.
Main Results:
- Macrolide prophylaxis in moderate-to-severe COPD patients significantly reduces exacerbation rates.
- Evidence suggests macrolides may decrease morbidity and potentially mortality in COPD.
- Emerging macrolide derivatives are being developed for their anti-inflammatory properties without antibacterial action.
Conclusions:
- The immunomodulatory and anti-inflammatory properties of antibiotics, particularly macrolides, are crucial for COPD management.
- Macrolide therapy offers a promising strategy for reducing COPD exacerbations and improving disease prognosis.
- Further research into non-antibacterial antibiotic derivatives could lead to new therapeutic approaches for COPD.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...